Related Topics News -

     
 Title only   |   Print 
     
泰格醫藥所屬投資平台悉售禮新醫藥3.41% 作價3,411萬美元

2025-07-17T  
《大行》花旗:第11批全國藥品集中採購顯示官方支持行業創新及理性競爭 料藥價降幅溫和

2025-07-17T  
《大行》花旗看好中國醫療板塊 首選藥明康德藥明生物

2025-07-11T  
《大行》交銀國際列出南向資金對港股各行業持倉分佈及配置集中度(表)

2025-07-04T  
《大行》交銀國際:南向資金近月主力配置集中醫療和金融板塊 反映對高息防禦價值重視

2025-07-04T  
泰格醫藥H股末期息支付日期改為7月11日

2025-06-19T  
《大行》大和升泰格醫藥目標價至38元 續籲「持有」

2025-06-13T  
《大行》美銀上調再鼎醫藥目標價至29.61元 升泰格醫藥目標價至40.1元

2025-06-11T  
《大行》里昂:生物科技股大致完成首階段估值修復 料流動性及基本面可改善

2025-06-10T  
《大行》匯豐研究降泰格醫藥目標價至39.5元 新增訂單超預期

2025-05-15T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.